Year To Quarter End Consolidated Statement Of Comprehensive Income

SymBio Pharmaceuticals Limited - Filing #7272884

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
-3,923,638,000 JPY
-3,833,480,000 JPY
-3,923,638,000 JPY
-3,923,638,000 JPY
-3,923,638,000 JPY
-1,986,723,000 JPY
-1,986,723,000 JPY
-1,962,817,000 JPY
-1,986,723,000 JPY
-1,986,723,000 JPY
Other comprehensive income
Foreign currency translation adjustment
13,879,000 JPY
6,228,000 JPY
Other comprehensive income
13,879,000 JPY
6,228,000 JPY
Comprehensive income
-3,819,600,000 JPY
-1,956,588,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-3,819,600,000 JPY
-1,956,588,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.